H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 3.06 HKD -0.33% Market Closed
Market Cap: 3.2B HKD

Intrinsic Value

The intrinsic value of one Hua Medicine stock under the Base Case scenario is 4.13 HKD. Compared to the current market price of 3.06 HKD, Hua Medicine is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.13 HKD
Undervaluation 26%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hua Medicine

What is Valuation History?
Ask AI Assistant
What other research platforms think about Hua Medicine?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hua Medicine valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hua Medicine.

Explain Valuation
Compare Hua Medicine to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hua Medicine?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hua Medicine

Current Assets 1.2B
Cash & Short-Term Investments 1B
Receivables 85.9m
Other Current Assets 133.4m
Non-Current Assets 177.9m
PP&E 118.1m
Intangibles 24.3m
Other Non-Current Assets 35.5m
Current Liabilities 159.5m
Accounts Payable 135.6m
Accrued Liabilities 30.1m
Other Current Liabilities -6.2m
Non-Current Liabilities 201.3m
Long-Term Debt 201.3m
Efficiency

Free Cash Flow Analysis
Hua Medicine

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hua Medicine

Revenue
370.7m CNY
Cost of Revenue
-175.9m CNY
Gross Profit
194.8m CNY
Operating Expenses
874.6m CNY
Operating Income
1.1B CNY
Other Expenses
6.6m CNY
Net Income
1.1B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hua Medicine's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional 3Y Average ROIC
Exceptional ROE
79/100
Profitability
Score

Hua Medicine's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hua Medicine's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
76/100
Solvency
Score

Hua Medicine's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hua Medicine

There are no price targets for Hua Medicine.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Hua Medicine
does not pay dividends
Shareholder Yield

Current shareholder yield for Hua Medicine is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hua Medicine stock?

The intrinsic value of one Hua Medicine stock under the Base Case scenario is 4.13 HKD.

Is Hua Medicine stock undervalued or overvalued?

Compared to the current market price of 3.06 HKD, Hua Medicine is Undervalued by 26%.

Back to Top